Business Wire Feed
Prestige Medical Group Announces New Woodstock Location, Expanding Access to Care in Cherokee County
WOODSTOCK, Ga.--(BUSINESS WIRE)--Prestige Medical Group, a physician-led healthcare organization serving North Georgia for more than 20 years, announced plans to open a new medical office in Woodstock, Georgia. The new location, opened on March 24, more...
Roseman University Launches Roseman Bioventures, a 120,000-square-foot Life Science Incubator in Las Vegas
- Aims to accelerate the commercialization of life science innovations and expand the Nevada biotech ecosystem -LAS VEGAS--(BUSINESS WIRE)--Roseman University of Health Sciences today announced the launch of Roseman Bioventures in Las Vegas to accelerate more...
NBDF’s Pathway to Cures Announces Spark Biomedical’s LUNA Trial to Advance Non-Pharmaceutical Options for Heavy Menstrual Bleeding
Phase II decentralized study evaluates transcutaneous auricular neurostimulation (tAN) for heavy menstrual bleeding, including participants with inherited bleeding disordersNEW YORK--(BUSINESS WIRE)--#bleedingdisorders--For women and girls with bleeding disorders, heavy menstrual bleeding (HMB) is one of the more...
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
− Efforts Aimed at Facilitating Earlier Diagnosis, Coordinated Care, and Long-Term Patient Impact in ATTR-CM – − Alnylam to Host TTR Investor Webinar Today at 9:30 am ET –CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), more...
KeyCare Deploys NVIDIA Nemotron to Power AI-Driven Clinical Intake at Scale
Clinician-validated AI intake reduces documentation burden and improves virtual care efficiencyCHICAGO--(BUSINESS WIRE)--#AIinHealthcare--KeyCare, the only national Epic-based virtual care group, today announced the deployment of NVIDIA’s Nemotron large language model in production to power its AI-driven more...
OnMed Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
OnMed joins the ranks of Google, Nvidia, Adidas, Walmart, and more WHITE PLAINS, N.Y.--(BUSINESS WIRE)--OnMed, the leader in tech-enabled hybrid healthcare, has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies more...
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
Last participant has been randomized and dosed in the LUCIDITY trial of avexitide; LUCIDITY enrolled a total of 78 participants Topline data readout on track; anticipated in Q3 2026 LUCIDITY is evaluating the FDA-agreed-upon primary more...
Towne Park Marks Its Next Chapter by Unveiling New Brand, Towne, as It Brings Together Its Best-in-Class Hospitality Solutions Capabilities and the Industry’s First Fully Integrated Technology Platform, Nexity by Towne
The new Towne brand reflects the company’s evolution into an arrival through departure experience company and introduces Nexity by Towne, its next-generation parking and mobility technology platformPLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--#BrandLaunch--Towne Park today announced the evolution more...
Experian Health’s 2026 State of Patient Access Survey Reveals Patient Experience Is Improving, but Big Challenges Remain for Healthcare Providers
Survey findings show financial friction and staffing issues remain significant barriersCOSTA MESA, Calif.--(BUSINESS WIRE)--Experian Health today released its annual 2026 State of Patient Access Survey, revealing that while operational efficiencies and digital tools are driving more...
Mosaic Therapeutics to Present Poster Highlighting Preclinical Data for Lead Program MOS101 at the American Association for Cancer Research (AACR) Annual Meeting 2026
First preclinical data on the Company’s lead program MOS101: a combination of ASTX295, a next-generation, clinical-stage MDM2 antagonist, and olaparib, an FDA-approved PARP inhibitor, in biomarker-selected solid tumors Additional data showcasing Mosaic’s Discovery Platform, PRIME, more...
Palm Primary Care Expands in Tarrant County with Acquisition of Two Clinics in Azle
Azle Central and Azle Parkway began operating as Palm Primary Care on March 1, 2026FORT WORTH, Texas--(BUSINESS WIRE)--#azle--Palm Primary Care (“Palm”), part of the MBF Healthcare Partners II, L.P. (“MBF”) portfolio and affiliated with Florida-based more...
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager
AMSTERDAM--(BUSINESS WIRE)--#Avanzanite--Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, more...
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters more...
Integrated DNA Technologies Expands into Clinical Diagnostics with First In Vitro Diagnostic
Milestone marks first of multiple planned diagnostic product launches on NGS roadmap Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro diagnostic BOULDER, Colo.--(BUSINESS WIRE)--#IVD--Global genomics leader Integrated DNA more...
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
Cencora reaffirms fiscal 2026 financial guidanceCONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners’ retina business for $1.1 billion. Upon completion of the transaction, the affiliated more...
Matrix Providers Inc. Announces Leadership Transition: Founder Dr. Bill Rivard to Become Chairman; Tricia Brown Named CEO
DENVER--(BUSINESS WIRE)--Matrix Providers Inc., a leading government healthcare staffing and workforce solutions provider serving military treatment facilities and federal healthcare agencies, today announced that founder and Chief Executive Officer Dr. Bill Rivard will transition to more...
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
Both primary effectiveness endpoints were met, demonstrating statistically significant and clinically meaningful intraocular pressure reduction. ELIOS is an implant-free procedure that uses excimer laser technology for the treatment of glaucoma. Topline results will be discussed more...
Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)
Positive Phase 3 results of SCOUT-HCM trial highlight potential of Camzyos to be the first cardiac myosin inhibitor for the treatment of adolescents with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) New real-world evidence further reinforces the more...
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above The investigational vaccine candidate was well tolerated with no safety concerns identified at time of more...
Oryon Cell Therapies Reports Phase 1b/2a Data Showing Sustained Motor Improvements in People with Parkinson’s Disease
Study conducted in collaboration with the Neuroregeneration Institute at McLean Hospital Autologous neuronal cell therapy for Parkinson’s disease shows sustained motor improvements and neuroimaging evidence of restored dopaminergic signaling Data presented at AD/PD™ 2026 International more...
Latent-Y: The Autonomous AI Agent for Drug Design at Scale
Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities From research goal to lab-ready sequences in hours: Latent-Y compresses weeks of expert work into autonomous design campaigns Lab-validated results more...
Almirall’s 17th Skin Academy Highlights Scientific Advances in Inflammatory Skin Diseases and Skin Cancer, Patient-Reported Outcomes, and Holistic Care in Medical Dermatology
Skin Academy brings together leading global experts to advance innovation, collaboration and scientific understanding in medical dermatology, with a focus on improving quality of life for people living with skin diseases. This year’s programme featured more...
Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing
The United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Contour* for the correction of temple hollowing, expanding its use beyond cheek augmentation and midface contour deficiencies to support overall facial balance and more...
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
DUBLIN--(BUSINESS WIRE)--$PRTA #Prothena--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced partner presentations on clinical updates from prasinezumab for the treatment more...
SunnyFit Celebrates 4-Year Anniversary with “Year 4 Everyone” Challenge and Community Giveaway Event
The free fitness platform marks milestone with multi-week challenge, new features, and livestream giveaway.INDUSTRY, Calif.--(BUSINESS WIRE)--SunnyFit, the free fitness app developed by Sunny Health & Fitness, is celebrating its fourth anniversary with the Year 4 more...